Literature DB >> 22892529

Clinical utility gene card for: Lynch syndrome (MLH1, MSH2, MSH6, PMS2, EPCAM) - update 2012.

Nils Rahner1, Verena Steinke, Brigitte Schlegelberger, Francois Eisinger, Pierre Hutter, Sylviane Olschwang.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22892529      PMCID： PMC3533316          DOI： 10.1038/ejhg.2012.164

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN： 1018-4813            Impact factor:   4.246


× No keyword cloud information.
  19 in total

Review 1.  Prophylactic surgery in Lynch syndrome.

Authors:  V Celentano; G Luglio; G Antonelli; R Tarquini; L Bucci
Journal:  Tech Coloproctol       Date:  2011-02-02       Impact factor: 3.781

2.  New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC.

Authors:  H F Vasen; P Watson; J P Mecklin; H T Lynch
Journal:  Gastroenterology       Date:  1999-06       Impact factor: 22.682

3.  Evaluation of predictive models in daily practice for the identification of patients with Lynch syndrome.

Authors:  Christophe Tresallet; Antoine Brouquet; Catherine Julié; Alain Beauchet; Céline Vallot; Fabrice Ménégaux; Emmanuel Mitry; François Radvanyi; Robert Malafosse; Philippe Rougier; Bernard Nordlinger; Pierre Laurent-Puig; Catherine Boileau; Jean-François Emile; Christine Muti; Christophe Penna; Hélène Hofmann-Radvanyi
Journal:  Int J Cancer       Date:  2011-07-25       Impact factor: 7.396

Review 4.  A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer.

Authors:  C R Boland; S N Thibodeau; S R Hamilton; D Sidransky; J R Eshleman; R W Burt; S J Meltzer; M A Rodriguez-Bigas; R Fodde; G N Ranzani; S Srivastava
Journal:  Cancer Res       Date:  1998-11-15       Impact factor: 12.701

5.  Microsatellite instability analysis and/or immunostaining for the diagnosis of hereditary nonpolyposis colorectal cancer?

Authors:  Britta Halvarsson; Annika Lindblom; Eva Rambech; Kristina Lagerstedt; Mef Nilbert
Journal:  Virchows Arch       Date:  2003-12-02       Impact factor: 4.064

6.  Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability.

Authors:  Asad Umar; C Richard Boland; Jonathan P Terdiman; Sapna Syngal; Albert de la Chapelle; Josef Rüschoff; Richard Fishel; Noralane M Lindor; Lawrence J Burgart; Richard Hamelin; Stanley R Hamilton; Robert A Hiatt; Jeremy Jass; Annika Lindblom; Henry T Lynch; Païvi Peltomaki; Scott D Ramsey; Miguel A Rodriguez-Bigas; Hans F A Vasen; Ernest T Hawk; J Carl Barrett; Andrew N Freedman; Sudhir Srivastava
Journal:  J Natl Cancer Inst       Date:  2004-02-18       Impact factor: 13.506

7.  Calculation of risk of colorectal and endometrial cancer among patients with Lynch syndrome.

Authors:  Elena Stoffel; Bhramar Mukherjee; Victoria M Raymond; Nabihah Tayob; Fay Kastrinos; Jennifer Sparr; Fei Wang; Prathap Bandipalliam; Sapna Syngal; Stephen B Gruber
Journal:  Gastroenterology       Date:  2009-07-18       Impact factor: 22.682

8.  Germline hypermethylation of MLH1 and EPCAM deletions are a frequent cause of Lynch syndrome.

Authors:  Renée C Niessen; Robert M W Hofstra; Helga Westers; Marjolijn J L Ligtenberg; Krista Kooi; Paul O J Jager; Marloes L de Groote; Trijnie Dijkhuizen; Maran J W Olderode-Berends; Harry Hollema; Jan H Kleibeuker; Rolf H Sijmons
Journal:  Genes Chromosomes Cancer       Date:  2009-08       Impact factor: 5.006

Review 9.  Prognostic value of Y deletion analysis: what is the clinical prognostic value of Y chromosome microdeletion analysis?

Authors:  C Krausz; L Quintana-Murci; K McElreavey
Journal:  Hum Reprod       Date:  2000-07       Impact factor: 6.918

10.  Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial.

Authors:  John Burn; Anne-Marie Gerdes; Finlay Macrae; Jukka-Pekka Mecklin; Gabriela Moeslein; Sylviane Olschwang; Diane Eccles; D Gareth Evans; Eamonn R Maher; Lucio Bertario; Marie-Luise Bisgaard; Malcolm G Dunlop; Judy W C Ho; Shirley V Hodgson; Annika Lindblom; Jan Lubinski; Patrick J Morrison; Victoria Murday; Raj Ramesar; Lucy Side; Rodney J Scott; Huw J W Thomas; Hans F Vasen; Gail Barker; Gillian Crawford; Faye Elliott; Mohammad Movahedi; Kirsi Pylvanainen; Juul T Wijnen; Riccardo Fodde; Henry T Lynch; John C Mathers; D Timothy Bishop
Journal:  Lancet       Date:  2011-10-27       Impact factor: 79.321
View more
  4 in total

1.  Clinical Utility Gene Card for: Familial adenomatous polyposis (FAP) and attenuated FAP (AFAP)--update 2014.

Authors:  Stefan Aretz; Hans F A Vasen; Sylviane Olschwang
Journal:  Eur J Hum Genet       Date:  2014-09-24       Impact factor: 4.246

2.  Methylation of SLFN11 promotes gastric cancer growth and increases gastric cancer cell resistance to cisplatin.

Authors:  Yaojun Peng; Li Wang; Liangliang Wu; Ling Zhang; Guangjun Nie; Mingzhou Guo
Journal:  J Cancer       Date:  2019-10-15       Impact factor: 4.207

3.  Clinical guideline seom: hereditary colorectal cancer.

Authors:  C Guillén-Ponce; R Serrano; A B Sánchez-Heras; A Teulé; I Chirivella; T Martín; E Martínez; R Morales; L Robles
Journal:  Clin Transl Oncol       Date:  2015-11-19       Impact factor: 3.405

4.  Molecular characteristics of synchronous multiple gastric cancer.

Authors:  Anqiang Wang; Zhongwu Li; Meng Wang; Shuqin Jia; Jiahu Chen; Ke Ji; Xin Ji; Xianglong Zong; Xiaojiang Wu; Ji Zhang; Ziyu Li; Lianhai Zhang; Ying Hu; Zhaode Bu; Qi Zheng; Jiafu Ji
Journal:  Theranostics       Date:  2020-04-07       Impact factor: 11.556
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.